Research in NSCLC has been inconclusive on this subject, with one study finding ROS1 copy number gain (CNG) to correlate with impaired disease-free and overall survival [26] but another finding no significant relationship [27]. Here, ROS1 is linked to non-small cell lung carcinoma.